Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET Imaging Targeting Nectin-4 in Malignant Tumors
NCT06994078Not yet recruiting
- Start
- Jul 2025
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Open-label, single-arm trial. Primary endpoint: Visual and standardized uptake values assessment of lesions and biodistribution at 1 year. Planned start Jul 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06994078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06994078.